Bradykinin B2 Receptor Antagonists
"Bradykinin B2 Receptor Antagonists" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Compounds and drugs that inhibit ligand binding or cellular signaling by BRADYKININ B2 RECEPTORS.
| Descriptor ID |
D065094
|
| MeSH Number(s) |
D27.505.519.265.500 D27.505.696.477.656.500.500
|
| Concept/Terms |
Bradykinin B2 Receptor Antagonists- Bradykinin B2 Receptor Antagonists
- Bradykinin B2 Receptor Blockers
- Bradykinin B2 Receptor Inhibitors
- Bradykinin B2 Antagonists
- Antagonists, Bradykinin B2
- B2 Antagonists, Bradykinin
|
Below are MeSH descriptors whose meaning is more general than "Bradykinin B2 Receptor Antagonists".
Below are MeSH descriptors whose meaning is more specific than "Bradykinin B2 Receptor Antagonists".
This graph shows the total number of publications written about "Bradykinin B2 Receptor Antagonists" by people in this website by year, and whether "Bradykinin B2 Receptor Antagonists" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2018 | 0 | 1 | 1 |
| 2019 | 0 | 1 | 1 |
| 2020 | 2 | 0 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Bradykinin B2 Receptor Antagonists" by people in Profiles.
-
Evaluation of the efficacy and safety of icatibant and C1 esterase/kallikrein inhibitor in severe COVID-19: study protocol for a three-armed randomized controlled trial. Trials. 2021 Jan 20; 22(1):71.
-
Icatibant in Severe Acute Respiratory Syndrome Coronavirus 2 Infection: A Case Report. J Investig Allergol Clin Immunol. 2021 Oct 25; 31(5):451-452.
-
Outcomes Associated With Use of a Kinin B2 Receptor Antagonist Among Patients With COVID-19. JAMA Netw Open. 2020 08 03; 3(8):e2017708.
-
Bradykinin as a Probable Aspect in SARS-Cov-2 Scenarios: Is Bradykinin Sneaking out of Our Sight? Iran J Allergy Asthma Immunol. 2020 May 17; 19(S1):13-17.
-
A hypothesized role for dysregulated bradykinin signaling in COVID-19 respiratory complications. FASEB J. 2020 06; 34(6):7265-7269.
-
Evaluation and Management of Angioedema in the Emergency Department. West J Emerg Med. 2019 Jul; 20(4):587-600.
-
Treatment patterns and healthcare resource utilization among patients with hereditary angioedema in the United States. Orphanet J Rare Dis. 2018 10 12; 13(1):180.
-
Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene. FASEB J. 2004 May; 18(7):828-35.